Publication of cancellation of entries for kinds of Medical Devices from the Australian Register of Therapeutic Goods - Medtel Pty Ltd - 157514

Overview

The Therapeutic Goods Act 1989, enacted by the Parliament of Australia, was introduced to regulate therapeutic goods, including medical devices, ensuring their safety, quality, and efficacy. The Act provides the legal framework for the Therapeutic Goods Administration (TGA) to manage the registration, evaluation, and monitoring of therapeutic goods available in Australia. A particular issue the Act addresses is the regulation of medical devices, ensuring that only those meeting specific standards and criteria are available for use. The cancellation of entries from the Australian Register of Therapeutic Goods (ARTG), as demonstrated in the provided Gazette, is an enforcement mechanism to uphold these standards. The policy objective is to protect public health by ensuring that only safe and effective therapeutic goods, including medical devices, are available to consumers. This Gazette, published by Dr Jane Cook, a delegate of the Secretary to the Department of Health, provides notice of the cancellation of an entry for a specific kind of medical device, a pillow, from the ARTG. The cancellation was due to the sponsor, Medtel Pty Ltd, failing to provide necessary information to substantiate compliance with the essential principles required for inclusion in the ARTG. This action aligns with the Act's objective to maintain high standards for therapeutic goods in Australia, ensuring that devices on the market are both safe and effective.

Scope and Application

The Therapeutic Goods Act 1989 applies to all medical devices in Australia, including those listed in the Australian Register of Therapeutic Goods (ARTG). This Act, administered by the Therapeutic Goods Administration (TGA) under the Department of Health, governs the regulation of therapeutic goods, including medical devices, across the Commonwealth of Australia. The Act applies to entities sponsoring or manufacturing medical devices, ensuring compliance with the essential principles for safety and performance. This legislation extends its reach to all medical devices marketed or supplied within Australia, irrespective of the manufacturer's location. However, the Act does not apply to medical devices that are exempt under certain conditions, such as those used for personal, non-commercial purposes or for research and development activities subject to specific exemptions. The application and enforcement of the Act may be extended through subordinate instruments, such as regulations and guidelines, which provide further detail on specific aspects of medical device regulation. In this case, the cancellation of a medical device from the ARTG under section 41GP of the Act highlights the importance of compliance with the essential principles, as failure to provide the necessary information can result in the removal of the device from the register.

Key Provisions

The primary operative section of this legislation is section 41GP of the Therapeutic Goods Act 1989 (the Act), which outlines the process for the cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods (ARTG). In this instance, the cancellation of the entry for a specific kind of pillow from the ARTG is being published (s.41GP). The cancellation is effective from 17 June 2014, as specified in the document signed by Dr. Jane Cook, a delegate of the Secretary to the Department of Health (s.41GP). The reasons for the cancellation are that the sponsor, Medtel Pty Ltd, did not provide information to substantiate compliance with the essential principles, leading to a failure to meet a condition that the inclusion of the device in the ARTG was subject to under section 41FN(3)(a) of the Act. The Act imposes certain obligations on the parties or entities it governs. For medical device sponsors, one of the key obligations is to provide information that substantiates compliance with the essential principles as required by the Act (s.41FN(3)(a)). This means that sponsors must ensure they have the necessary evidence and documentation to demonstrate that their devices meet the safety and performance standards set out in the Act. Failure to provide such information when requested can lead to the cancellation of the device's entry from the ARTG. In this case, Medtel Pty Ltd did not meet this requirement, resulting in the cancellation of the pillow's entry from the ARTG. In terms of consequences for non-compliance, the Therapeutic Goods Act 1989 does not explicitly state penalties for the failure to provide information to substantiate compliance with the essential principles. However, the cancellation of an entry from the ARTG can have significant implications for the sponsor, including loss of market access for the device in Australia. Additionally, repeated or serious non-compliance could potentially lead to further regulatory action, including potential fines or other enforcement measures under different sections of the Act. The Act provides for a range of civil and criminal penalties for various offences, but the specific penalties for the scenario described are not detailed in the provided text.